HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Other Non-Current Assets of $34.2 million for Q2 2026, down 15.83% year-over-year from $40.6 million in Q2 2025, and up 231.27% quarter-over-quarter from $10.3 million in Q4 2025.
HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Other Non-Current Assets for 12 consecutive years, with $34.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 15.83% year-over-year to $34.2 million; the TTM figure through Jun 2026 stood at $34.2 million (down 15.83% YoY), while the FY2025 annual figure was $38.9 million, up 212.51% from the prior year.
- Other Non-Current Assets climbed to $34.2 million in Q2 2026 per HCM's latest filing, from $10.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.5 billion in Q4 2023 and bottomed at $4.8 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $518.9 million across 5 years, with a median of $37.3 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 87351.98% — and 2024, when it sank 99.89%.
- HUTCHMED (China)'s Other Non-Current Assets stood at $5.1 million in 2022, then surged by 87351.98% to $4.5 billion in 2023, then tumbled by 99.89% to $4.8 million in 2024, then jumped by 114.65% to $10.3 million in 2025, then surged by 231.27% to $34.2 million in 2026.
- Business Quant data shows HCM's Other Non-Current Assets at $34.2 million in Q2 2026, $10.3 million in Q4 2025, and $40.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | 34.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.19 Mn |
| Dec 31, 2025 | 10.32 Mn |
| Jun 30, 2025 | 40.62 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Jun 30, 2024 | 37.27 Mn |
| Dec 31, 2023 | 4.45 Bn |
| Jun 30, 2023 | 39.55 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Jun 30, 2022 | 45.04 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Jun 30, 2021 | 24.71 Mn |
| Mar 31, 2021 | 26.97 Mn |
| Dec 31, 2020 | 20.17 Mn |
| Jun 30, 2020 | 6.64 Mn |
| Dec 31, 2019 | 5.78 Mn |
| Sep 30, 2019 | 6.58 Mn |
| Jun 30, 2019 | 6.77 Mn |
| Mar 31, 2019 | 6.77 Mn |
| Dec 31, 2018 | 292,000.00 |
| Jun 30, 2018 | 6.58 Mn |